NASDAQ:XOMA XOMA (XOMA) Stock Price, News & Analysis $27.13 +0.51 (+1.92%) (As of 12/24/2024 01:48 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About XOMA Stock (NASDAQ:XOMA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get XOMA alerts:Sign Up Key Stats Today's Range$26.42▼$27.1350-Day Range$25.11▼$33.8852-Week Range$18.03▼$35.00Volume13,770 shsAverage Volume23,070 shsMarket Capitalization$319.67 millionP/E RatioN/ADividend YieldN/APrice Target$81.50Consensus RatingBuy Company OverviewXOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.Read More… XOMA Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks86th Percentile Overall ScoreXOMA MarketRank™: XOMA scored higher than 86% of companies evaluated by MarketBeat, and ranked 154th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingXOMA has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageXOMA has only been the subject of 1 research reports in the past 90 days.Read more about XOMA's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for XOMA are expected to grow in the coming year, from ($0.79) to ($0.55) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of XOMA is -7.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of XOMA is -7.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXOMA has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.96% of the outstanding shares of XOMA have been sold short.Short Interest Ratio / Days to CoverXOMA has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in XOMA has recently decreased by 13.65%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldXOMA does not currently pay a dividend.Dividend GrowthXOMA does not have a long track record of dividend growth. Sustainability and ESG3.0 / 5Environmental Score-0.22 Percentage of Shares Shorted0.96% of the outstanding shares of XOMA have been sold short.Short Interest Ratio / Days to CoverXOMA has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in XOMA has recently decreased by 13.65%, indicating that investor sentiment is improving significantly. News and Social Media2.3 / 5News Sentiment0.19 News SentimentXOMA has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for XOMA this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for XOMA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added XOMA to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, XOMA insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $655,336.00 in company stock.Percentage Held by InsidersOnly 7.20% of the stock of XOMA is held by insiders.Percentage Held by Institutions95.92% of the stock of XOMA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about XOMA's insider trading history. Receive XOMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address XOMA Stock News HeadlinesXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendDecember 19, 2024 | seekingalpha.comXOMA Preferred Shares Series A declares $0.5391 dividendDecember 19, 2024 | seekingalpha.comMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.December 25, 2024 | Brownstone Research (Ad)XOMA Royalty Declares Quarterly Preferred Stock DividendsDecember 19, 2024 | globenewswire.comHC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA)December 16, 2024 | americanbankingnews.comXoma’s Strategic Partnerships and Promising Pipeline Drive Buy RatingDecember 14, 2024 | markets.businessinsider.comA Glimpse Into The Expert Outlook On XOMA Royalty Through 4 AnalystsDecember 3, 2024 | benzinga.comStrategic Acquisitions and Growth Potential Bolster Xoma’s Buy RatingDecember 3, 2024 | markets.businessinsider.comSee More Headlines XOMA Stock Analysis - Frequently Asked Questions How have XOMA shares performed this year? XOMA's stock was trading at $18.50 at the beginning of 2024. Since then, XOMA shares have increased by 46.6% and is now trading at $27.13. View the best growth stocks for 2024 here. How were XOMA's earnings last quarter? XOMA Co. (NASDAQ:XOMA) released its earnings results on Thursday, November, 4th. The biotechnology company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.31. The biotechnology company earned $0.94 million during the quarter, compared to analysts' expectations of $6.36 million. XOMA had a negative trailing twelve-month return on equity of 24.95% and a negative net margin of 151.34%. Who are XOMA's major shareholders? Top institutional shareholders of XOMA include FMR LLC (9.36%), Stonepine Capital Management LLC (1.66%), Geode Capital Management LLC (1.55%) and State Street Corp (1.21%). Insiders that own company stock include Bvf Partners L P/Il, Owen Hughes, James R Neal, Thomas M Burns and Bradley Sitko. View institutional ownership trends. How do I buy shares of XOMA? Shares of XOMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of XOMA own? Based on aggregate information from My MarketBeat watchlists, some other companies that XOMA investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC). Company Calendar Last Earnings11/04/2021Today12/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:XOMA CUSIP98419J10 CIK791908 Webwww.xoma.com Phone(510) 204-7200Fax510-649-7571Employees10Year Founded1981Price Target and Rating Average Stock Price Target$81.50 High Stock Price Target$123.00 Low Stock Price Target$40.00 Potential Upside/Downside+200.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($3.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-40,830,000.00 Net Margins-151.34% Pretax Margin-138.67% Return on Equity-24.95% Return on Assets-9.64% Debt Debt-to-Equity Ratio1.28 Current Ratio7.52 Quick Ratio7.52 Sales & Book Value Annual Sales$9.71 million Price / Sales32.92 Cash FlowN/A Price / Cash FlowN/A Book Value$7.72 per share Price / Book3.51Miscellaneous Outstanding Shares11,783,000Free Float10,935,000Market Cap$319.67 million OptionableOptionable Beta0.88 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:XOMA) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.